참고문헌 (44)

1. Allen T , McEvoy J , Keefe R ( 2003 ) Galantamine as an adjunctive therapy in the treatment of schizophrenia . Paper presented at: 11th Congress of the International Psychogeriatric Association (IPA) ; August 17–22, 2003 ; Chicago, IL . 

2. Andreasen NC ( 1982 ) Negative symptoms in schizophrenia. Definition and reliability . Arch Gen Psychiatry 39 : 784 – 788 . 7165477 

   상세보기

3. Arnold SE , Trojanowski JQ ( 1996 ) Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology . Schizophr Bull 22 : 5 – 9 . 8685663 

   상세보기

4. Buchanan RW , Kelly DL , Weiner E , Gold JM , Strauss GP , Koola MM , McMahon RP , Carpenter WT ( 2017 ) A randomized clinical trial of oxytocin or galantamine for the treatment of negative symptoms and cognitive impairments in people with schizophrenia . J Clin Psychopharmacol 37 : 394 – 400 . 28590362 

   상세보기

5. Choi KH , Wykes T , Kurtz MM ( 2013 ) Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy . Br J Psychiatry 203 : 172 – 178 . 23999481 

   상세보기

6. Collaboration TC ( 2014 ) Review Manager (RevMan) [computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre . 

7. Correll CU , Rubio JM , Inczedy-Farkas G , Birnbaum ML , Kane JM , Leucht S ( 2017 ) Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence . JAMA Psychiatry 74 : 675 – 684 . 28514486 

   상세보기

8. de Lucena D , Fernandes BS , Berk M , Dodd S , Medeiros DW , Pedrini M , Kunz M , Gomes FA , Giglio LF , Lobato MI , Belmonte-de-Abreu PS , Gama CS ( 2009 ) Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine . J Clin Psychiatry 70 : 1416 – 1423 . 19906345 

   상세보기

9. Erickson SK , Schwarzkopf SB , Palumbo D , Badgley-Fleeman J , Smirnow AM , Light GA ( 2005 ) Efficacy and tolerability of low-dose donepezil in schizophrenia . Clin Neuropharmacol 28 : 179 – 184 . 16062097 

   상세보기

10. Fleischhacker WW , Kemmler G ( 2007 ) The clinical relevance of percentage improvements on the PANSS score . Neuropsychopharmacology 32 : 2435 – 2436 . 17940536 

    상세보기

11. Folstein MF , Folstein SE , McHugh PR ( 1975 ) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician . Psychiatry Res 12 : 189 – 198 . 

12. Friedman JI , Adler DN , Howanitz E , Harvey PD , Brenner G , Temporini H , White L , Parrella M , Davis KL ( 2002 ) A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia . Biol Psychiatry 51 : 349 – 357 . 11904128 

    상세보기

13. Green MF , Nuechterlein KH , Gold JM , Barch DM , Cohen J , Essock S , Fenton WS , Frese F , Goldberg TE , Heaton RK , Keefe RS , Kern RS , Kraemer H , Stover E , Weinberger DR , Zalcman S , Marder SR ( 2004 ) Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria . Biol Psychiatry 56 : 301 – 307 . 15336511 

    상세보기

14. Guy W , Bonato RR ( 1970 ) Manual for the ECDEU assessment battery , 2nd ed Chevy Chase, MD : National Institute of Mental Health . 

15. Heilbronner U , Samara M , Leucht S , Falkai P , Schulze TG ( 2016 ) The longitudinal course of schizophrenia across the lifespan: clinical, cognitive, and neurobiological aspects . Harv Rev Psychiatry 24 : 118 – 128 . 26954596 

16. Higgins J , Green S ( 2011 ) Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011) Available at: http://handbook.cochrane.org . 

17. Hussain M , Chaudhry Z ( 2003 ) Rivastigmine and galantamine treatment for schizophrenic cognitive impairment . Paper presented at: The 156th Annual Meeting of the American Psychiatric Association ; May 17–22, 2003 ; San Francisco, CA . 

18. Iwata Y , Nakajima S , Suzuki T , Keefe RS , Plitman E , Chung JK , Caravaggio F , Mimura M , Graff-Guerrero A , Uchida H ( 2015 ) Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials . Mol Psychiatry 20 : 1151 – 1160 . 26077694 

    상세보기

19. Kay SR , Opler LA , Lindenmayer JP ( 1989 ) The Positive and negative syndrome scale (PANSS): rationale and standardisation . Br J Psychiatry 59 – 67 . 

20. Keefe RS , Malhotra AK , Meltzer HY , Kane JM , Buchanan RW , Murthy A , Sovel M , Li C , Goldman R ( 2008 ) Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial . Neuropsychopharmacology 33 : 1217 – 1228 . 17625502 

    상세보기

21. Kishi T , Matsuda Y , Iwata N ( 2017 ) Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis . Psychopharmacology (Berl) 234 : 2113 – 2125 . 28508107 

22. Kumar V , Shivakumar V , Chhabra H , Bose A , Venkatasubramanian G , Gangadhar BN ( 2017 ) Functional near infra-red spectroscopy (fNIRS) in schizophrenia: a review . Asian J Psychiatr 27 : 18 – 31 . 28558892 

    상세보기

23. Lang FU , Kösters M , Lang S , Becker T , Jäger M ( 2013 ) Psychopathological long-term outcome of schizophrenia – a review . Acta Psychiatr Scand 127 : 173 – 182 . 23136879 

    상세보기

24. LeLorier J , Grégoire G , Benhaddad A , Lapierre J , Derderian F ( 1997 ) Discrepancies between meta-analyses and subsequent large randomized, controlled trials . N Engl J Med 337 : 536 – 542 . 9262498 

    상세보기

25. Leucht S , Cipriani A , Spineli L , Mavridis D , Orey D , Richter F , Samara M , Barbui C , Engel RR , Geddes JR , Kissling W , Stapf MP , Lässig B , Salanti G , Davis JM ( 2013 ) Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis . Lancet 382 : 951 – 962 . 23810019 

26. Lieberman JA , Papadakis K , Csernansky J , Litman R , Volavka J , Jia XD , Gage A , MEM-MD-29 Study Group ( 2009 ) A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia . Neuropsychopharmacology 34 : 1322 – 1329 . 19005465 

    상세보기

27. Mazeh D , Zemishlani H , Barak Y , Mirecki I , Paleacu D ( 2006 ) Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study . Int Psychogeriatr 18 : 429 – 436 . 16478570 

    상세보기

28. Miyamoto S , Miyake N , Jarskog LF , Fleischhacker WW , Lieberman JA ( 2012 ) Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents . Mol Psychiatry 17 : 1206 – 1227 . 22584864 

    상세보기

29. Moher D , Liberati A , Tetzlaff J , Altman DG , PRISMA Group ( 2009 ) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement . Bmj 339 : b2535 . 19622551 

    상세보기

30. Naci H , Dias S , Ades AE ( 2014 ) Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins . Bmj 349 : g5741 . 25281681 

31. Nielsen RE , Levander S , Kjaersdam Telléus G , Jensen SO , Østergaard Christensen T , Leucht S ( 2015 ) Second-generation antipsychotic effect on cognition in patients with schizophrenia–a meta-analysis of randomized clinical trials . Acta Psychiatr Scand 131 : 185 – 196 . 25597383 

    상세보기

32. Omranifard V , Rajabi F , Mohammadian-Sichani M , Maracy MR ( 2017 ) The effect of add-on memantine on positive, negative and depressive symptoms of schizophrenia: a doubleblind, randomized, controlled trial . Actas Esp Psiquiatr 45 : 108 – 115 . 28594056 

33. Overall JE , Gorham DR ( 1962 ) The brief psychiatric rating scale . Psychol Rep 10 : 799 – 812 . 

34. Parsons CG , Danysz W , Dekundy A , Pulte I ( 2013 ) Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer’s disease . Neurotox Res 24 : 358 – 369 . 23657927 

    상세보기

35. Ribeiz SR , Bassitt DP , Arrais JA , Avila R , Steffens DC , Bottino CM ( 2010 ) Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature . CNS Drugs 24 : 303 – 317 . 20297855 

    상세보기

36. Sacco KA , Creeden C , Reutenauer EL , George TP ( 2008 ) Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia . Schizophr Res 103 : 326 – 327 . 18571377 

    상세보기

37. Sarter M ( 1994 ) Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin ? Psychopharmacology (Berl) 114 : 539 – 550 . 7855215 

38. Scheltens P , Blennow K , Breteler MM , de Strooper B , Frisoni GB , Salloway S , Van der Flier WM ( 2016 ) Alzheimer’s disease . Lancet 388 : 505 – 517 . 26921134 

39. Singh J , Kour K , Jayaram MB ( 2012 ) Acetylcholinesterase inhibitors for schizophrenia . Cochrane Database Syst Rev 1 : CD007967 . 22258978 

40. Sterne JA , Gavaghan D , Egger M ( 2000 ) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature . J Clin Epidemiol 53 : 1119 – 1129 . 11106885 

    상세보기

41. Swerdlow NR , Bhakta S , Chou HH , Talledo JA , Balvaneda B , Light GA ( 2016 ) Memantine effects on sensorimotor gating and mismatch negativity in patients with chronic psychosis . Neuropsychopharmacology 41 : 419 – 430 . 26062785 

    상세보기

42. van Os J , Kapur S ( 2009 ) Schizophrenia . Lancet 374 : 635 – 645 . 19700006 

43. Velakoulis D , Walterfang M , Mocellin R , Pantelis C , McLean C ( 2009 ) Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases . Br J Psychiatry 194 : 298 – 305 . 19336778 

    상세보기

44. Villarroya M , García AG , Marco-Contelles J , López MG ( 2007 ) An update on the pharmacology of galantamine . Expert Opin Investig Drugs 16 : 1987 – 1998 .